Camylofin
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | A03AA03 (WHO) |
Identifiers | |
| |
CAS Number | 54-30-8 |
PubChem (CID) | 5902 |
ChemSpider | 5691 |
UNII | 340B6Q764V |
ChEMBL | CHEMBL253592 |
ECHA InfoCard | 100.000.184 |
Chemical and physical data | |
Formula | C19H32N2O2 |
Molar mass | 320.47 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Camylofin is an antimuscarinic.
Camylofin is a smooth muscle relaxant with both anticholinergic action as well as direct smooth muscle action. Anticholinergic action is produced by inhibiting the binding of acetylcholine to muscarinic receptors, but the action is less pronounced. Direct smooth muscle relaxation is achieved by inhibiting phosphodiesterase type IV, which leads to increased cyclic AMP and eventually reduced cytosolic calcium. Thus camylofin has a comprehensive action to relieve smooth muscle spasm.pyrexia.
This article is issued from Wikipedia - version of the 6/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.